Sloning to Synthesize Genes Using Automated Technology | GenomeWeb

NEW YORK, July 19 (GenomeWeb News) - Sloning Biotechnology has entered the synthetic gene-production market this month with an automated process, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.